Form 4 for BVS Bioventus Inc.
Accepted 2022-02-15 00:00:00 ET · period of report 2022-02-11 · accession 0000899243-22-006562 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-15 | 2022-02-11 | BVS | Pavesio Alessandra | SVP, CSO | M - OptEx | — | +1,470 | 120.3K | +1% | — |
| D | 2022-02-15 | 2022-02-11 | BVS | Pavesio Alessandra | SVP, CSO | M - OptEx | $0.00 | -1,470 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-02-11 | M | A | 1,470 | — | 120,263 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. |
| 2 | Derivative | Restricted Stock Units | 2022-02-11 | M | D | 1,470 | $0.00 | 0 | D | — · — to — | 1,470 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of Class A common stock. (F2) The restricted stock units vested on February 11, 2022. |